Develops instruments and software for analyzing biological systems in oncology, immunology, and neuroscience research.
Jun 2026Revenue $617M/yrExpenses $705M/yr
No trend
Figures by year
When will 10x Genomics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $617M and expenses $705M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $643M | $704M | −$61.0M |
| Dec 2024 | $611M | $805M | −$195M |
| Dec 2023 | $619M | $884M | −$265M |
| Dec 2022 | $516M | $684M | −$168M |
| Dec 2021 | $490M | $543M | −$52.3M |
| Dec 2020 | $299M | $833M | −$534M |
| Dec 2019 | $246M | $276M | −$30.6M |
| Dec 2018 | $146M | $257M | −$111M |
| Dec 2017 | $71.1M | $89.5M | −$18.4M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.